Skip to main content
. 2023 Jul 28;13:12241. doi: 10.1038/s41598-023-39491-x

Figure 1.

Figure 1

Oral administration of 5-aminosalicylic acid alters the gut bacterial composition. (A) The study design of oral 5-aminosalicylic acid (5-ASA) administration. Fecal samples were collected at weeks 0, 2, and 4. Mice were sacrificed to collect tissues at week 4. (B) Changes in the Shannon diversity index over time in female animals treated with 5-ASA. (C) PCoA plots based on unweighted and weighted UniFrac distances of the intestinal bacterial compositions in female animals. (D) Heatmap of relative abundances of bacterial phyla over time in female animals. Each row represents a single DNA sample, and each column represents each phylum. (E) Changes in the relative abundances of phyla Firmicutes and Bacteroidetes over time in female animals. (F) Changes in the relative abundance of phylum Actinobacteria in female animals. *p < 0.05, **p < 0.01, Mann–Whitney U-test. The data are described as the mean ± SEM. Male data are shown in Supplemental Figure S1. Heatmap was generated by Pretty Heatmaps (version 1.0.12) (https://cran.r-project.org/web/packages/pheatmap).